Top Companies in Vitamin C Market | Leading Players in Vitamin C Industry Size, Share, Strategies, Market Analysis
Global Vitamin-C Market is valued at in 2022 and is projected to reach a value of USD 1.8 Billion by 2028 at a CAGR (Compound Annual Growth Rate) of 6.1% over the forecast period.
Coralia.Joe
Market Overview:
The Global Vitamin C Market is valued at in 2022 and is projected to reach a value of USD 1.8 Billion by 2028 at a CAGR (Compound Annual Growth Rate) of 6.1% over the forecast period. The Vitamin C Market is anticipated to expand well in the coming years owing to its grown use in numerous food items or the use of Vitamin C as supplements. The demand for food products with significant Vitamin C content is rising. Vitamin C is vital since it aids in the body's cell repair process and is crucial in preventing various cardiac problems. The market is anticipated to expand in the next years due to the rising demand for Vitamin-C supplements and even food products that are rich in vitamins.
There was a greater demand for Vitamin C supplements during the epidemic. Vitamin-C supplements were used to alleviate the COVID-19 virus's minor symptoms. Due to increased concerns about immunity, there was an increasing demand for these supplements. The market for Vitamin-C is expanding as a result of the rising demand for goods with natural ingredients that can be useful in supplying antioxidants. Due to growing production in the pharmaceutical and healthcare industries, the demand for Vitamin C products has surged.
Get Access to Our Free Sample Report: https://www.vantagemarketresearch.com/vitamin-c-market-1869/request-sample
Some of the key players operating in the Vitamin C Market are listed below:
|
Company Name |
Revenue in USD |
|
$4 Billion |
|
<$5 Million |
|
$4 Billion |
|
<$5 Million |
|
$9 Billion |
|
$1 Billion |
|
<$5 Million |
|
<$5 Million |
|
$1 Billion |
CSPC Pharmaceutical Group Limited is one of the largest drug manufacturers in China. The CSPC Pharmaceutical Group Limited's product line includes a variety of generic, bulk, and newly formulated medications. In addition, cardio-cerebrovascular illnesses, digestive and metabolic disorders, oncology, neurology, and anti-infectives are the main topics of the company's Research and Development (R&D) pipeline.
The owner of a multi-business conglomerate planned intended to provide different chemicals. The company specializes in the production of new biological materials such as polylactic acid, starch sugar products, alanine, lysine, and a variety of vitamins and has manufacturing subsidiaries in the fields of gelatin, food, biochemical, equipment, and several trading companies both domestically and abroad. This enables customers in the production sector to obtain trustworthy goods.
Glanbia PLC is an Irish global nutrition group with operations in 32 countries. It has leading market positions in dairy ingredients, sports nutrition, cheese, specialty non-dairy ingredients, mineral premixes, and vitamins. Glanbia plc products are sold or distributed in over around 130 countries. While Europe and the USA represent the most significant markets, the Group is continuing to expand into the Middle East, Africa, Asia Pacific, and Latin America. Glanbia is listed in the Irish.
Provider of functional food ingredients for the food industry in the U.K. and Ireland. The company's products include whey protein concentrates, total milk protein, whey permeate powder, milk permeates powder, yogurt powders, cream powders, autolyzed yeast extracts, yeast cell walls, inactive dried yeast, vinegar powder, and honey powder.
Koninklijke DSM, a multinational corporation focused on research, and active in the areas of sustainable living, nutrition, and health, is headquartered in the Netherlands. Solutions for animal nutrition and feed, medicines, food & beverages, medical nutrition, early life nutrition, dietary supplements, nutrition improvement, and personal care are offered by the Koninklijke DSM N.V. business.
Northeast Pharmaceutical Group Co Ltd is engaged in producing and distributing ammonium phosphate, sulfuric acid, cement, compound fertilizer, bromine, raw salt, and diammonium phosphate.
Manufacturer and exporter of enzyme products. The company's enzyme products include glucoamylase, a-amylase, cellulose, ß-glucanase, xylanase, feed enzymes, ß-amylase, special beer enzymes, industrial, juice, and flour industrial, paper-making enzymes and plant extracts with enzymes.
The Company is a developer of microparticles and microcapsules for preserving pharmacological ingredients in medicines or flavors in cosmetics. The company's products have a multichannel setup that enables scalability, high precision size control that works with most chemicals and batch sizes runs around the clock, requires little labor, and enables pharmaceutical companies to maintain laboratory precision at high volume throughout the process.
North China Pharmaceutical Co. Ltd. is engaged in manufacturing and selling antibiotics, vitamins, and pharmaceutical products in China. The main products of the company include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Read Our Latest Blog: Top Companies in Niacinamide Market
Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: Vantage Market Research
Follow Us on
